Exchange Traded Concepts LLC grew its stake in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 6.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 146,097 shares of the technology company’s stock after purchasing an additional 8,854 shares during the quarter. Exchange Traded Concepts LLC owned approximately 0.41% of Novanta worth $18,836,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in NOVT. Parallel Advisors LLC boosted its stake in shares of Novanta by 1,426.7% during the first quarter. Parallel Advisors LLC now owns 229 shares of the technology company’s stock valued at $29,000 after purchasing an additional 214 shares during the period. SVB Wealth LLC purchased a new stake in shares of Novanta during the first quarter valued at $48,000. GAMMA Investing LLC boosted its stake in shares of Novanta by 146.0% during the first quarter. GAMMA Investing LLC now owns 401 shares of the technology company’s stock valued at $51,000 after purchasing an additional 238 shares during the period. CWM LLC raised its holdings in shares of Novanta by 329.8% in the first quarter. CWM LLC now owns 404 shares of the technology company’s stock valued at $52,000 after acquiring an additional 310 shares in the last quarter. Finally, Signaturefd LLC raised its holdings in shares of Novanta by 80.0% in the first quarter. Signaturefd LLC now owns 414 shares of the technology company’s stock valued at $53,000 after acquiring an additional 184 shares in the last quarter. 98.35% of the stock is owned by hedge funds and other institutional investors.
Novanta Price Performance
Shares of NASDAQ NOVT opened at $112.97 on Thursday. The business’s 50 day moving average price is $119.62 and its 200 day moving average price is $123.44. The firm has a market cap of $4.06 billion, a P/E ratio of 66.45 and a beta of 1.50. Novanta Inc. has a 52 week low of $98.76 and a 52 week high of $184.11. The company has a quick ratio of 1.62, a current ratio of 2.54 and a debt-to-equity ratio of 0.57.
Analysts Set New Price Targets
Several analysts recently weighed in on the company. Wall Street Zen downgraded Novanta from a “buy” rating to a “hold” rating in a report on Monday, August 11th. Robert W. Baird decreased their price objective on Novanta from $139.00 to $133.00 and set a “neutral” rating for the company in a report on Monday, August 11th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $133.00.
View Our Latest Analysis on Novanta
About Novanta
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Further Reading
- Five stocks we like better than Novanta
- High Flyers: 3 Natural Gas Stocks for March 2022
- DoorDash Buys Deliveroo: A Game Changer?
- Why Are These Companies Considered Blue Chips?
- Is Netflix’s Ad Deal With Amazon the Catalyst for a New Uptrend?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Clearway Energy’s Price Dip: 3 Reasons It’s a Signal to Buy
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.